For device makers and drug companies, going through the process of clinical trials for new treatments is expensive and time consuming. But they have to do it to get FDA approval. Part of the problem is a data problem. Biosciences companies need a virtual hub where all the clinical information lives, and where it can be […]
For device makers and drug companies, going through the process of clinical trials for new treatments is expensive and time consuming. But they have to do it to get FDA approval. Part of the problem is a data problem. Biosciences companies need a virtual hub where all the clinical information lives, and where it can be […]
Share this Article
Recommended